Back in 2023, I wrote a short piece comparing Hims & Hers to Amazon in its early days. It wasn’t something I shared publicly at the time. I was just trying to make sense of what I was seeing—and more importantly, what I was buying.

HIMS was hated. Retail sentiment was dead. The stock had dropped from a euphoric EV/sales multiple of 31x down to 1.3x. But when I zoomed out, it felt like Amazon in 2001.

Here’s what I wrote:

The resemblances between Hims & Hers and Amazon are so significant, it cannot be a coincidence.

#1: IPO during the rise of a bubble
Amazon IPO’d in 1999 at the peak of dot-com greed—trading at 48x EV/sales. Two years later, it cratered to 1.2x at the depths of fear.
HIMS IPO’d in 2021 at 31x EV/sales. One year later, it was down to 1.3x.
Emotion created the opportunity for both companies. And for bold investors.

#2: From hypergrowth to consistent growth
Amazon cooled from triple-digit growth to 20–40% and stayed there for 20+ years.
HIMS is showing the same trajectory, with growth stabilizing around 20–40% based on 2024 guidance.

#3: The transition to profitability
In 2001, Amazon showed its first net income. The stock popped +24%.
In Q4 2023, HIMS reported its first profitable quarter. The stock jumped +31% in one day.

#4: A dream team
Bezos brought in strong operators (ex-GE, EA) to scale the business and navigate profitability.
Dudum has done the same—bringing in a CFO from Uber/Google and a board member from Netflix who personally bought $3M worth of shares.

#5: Obsession with customer experience
Both companies reinvested in value—lowering prices, building trust, and playing the long game.

❝

“We earn trust with customers over time... that actually does maximize free cash flow.” – Jeff Bezos

“We’ve begun systematically lowering prices to make our offerings more mass market accessible.” – Andrew Dudum

Why I’m Still Buying $HIMS in 2025

Since then, the company has executed flawlessly — and the market is still underestimating what they’re building.

Let’s break it down:
Founder-led with a long-term vision. Andrew Dudum, CEO of $HIMS, has compared their roadmap to early $AMZN and $NFLX. But the market hasn’t caught up. Hims & Hers is far more than just a GLP-1 weight-loss trade.

  • Subscriber growth is on fire. They're delivering deeply personalized treatment and expanding into new categories. 2.4 million total subscribers. That’s a 38% YoY increase.

  • Global expansion is underway. $HIMS acquired Zava, a telemedicine leader in Europe, bringing 1.3M users and a fast track to international scale.

  • AI-powered data loop. Every new user improves the product, which leads to better outcomes, more trust, and more users. It’s the same compounding flywheel Netflix and Spotify used to dominate.

  • 58% of users are now on personalized treatment. That’s up 136% YoY and trending toward 100%. This isn’t generic healthcare. It’s precision care at scale.

  • The $NVO partnership fallout? Not a problem. $HIMS posted 111% revenue growth YoY in Q1 — without leaning on Novo’s Wegovy. The breakup just proved that HIMS is committed to treating individuals, not just trends.

  • Valuation remains irrationally low. Price-to-sales ratios: $HIMS at 5.27x. PLTR at 106x. DUOL at 25.13x. HOOD at 20.67x. You’re getting real growth with real margins at a sane multiple.

  • 2030 forecast is $6.5B in revenue. Even at today’s multiple, that implies a ~$35B market cap. That’s a 4x from current levels. Re-rating optional. Execution mandatory.

  • The setup today? Just as strong as 2022. Rapid subscriber growth. AI + data flywheel. Disciplined leadership. Dirt-cheap valuation.

I’m still buying. Not because the stock is cheap. But because the business is strong — and getting stronger.

This is how multibaggers are made.

I’m not here to flex that I got it right. I’m sharing this because it’s how I build conviction—by studying the DNA of companies during the storm, not after the rally.

$HIMS is now up over 1,200% from those lows. That one position changed how I look at asymmetric bets forever.

I still look for that same setup:

  • Undervalued by the market

  • Inflecting on fundamentals

  • Led by mission-driven operators

Right now, I’m building positions in four companies that fit that exact mold:
$LMND, $SOFI, $HIMS (still), and $OSCR.

Each of them is going through some version of the HIMS journey. If you want the full breakdown on why I’m buying these names, read the post here:
What I’m Buying Right Now for Asymmetric Upside →

We’re still early.

— Connor
Founder Partner, Black Sheep Capital
Dad of 3, part-time freight operator, full-time misfit

Subscribe to Alpha Before It Prints for deep dives like this—before the story breaks wide open.

🔗 Connect with me:
✖️ Twitter | 💼 LinkedIn | 🚀 Subscribe

© 2025 Alpha Before It Prints
Unsubscribe